|
Aug 7
|
Exploring 3 High Growth Tech Stocks In The US Market
|
|
Aug 1
|
High Growth US Tech Stocks To Watch In August 2025
|
|
Jul 31
|
Exploring US High Growth Tech Stocks For July 2025
|
|
Jul 31
|
Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Misses Revenue Estimates
|
|
Jul 31
|
High Growth Tech Stocks in the US for July 2025
|
|
Jul 31
|
Vanda: Q2 Earnings Snapshot
|
|
Jul 31
|
Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results
|
|
Jul 30
|
Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Beats Revenue Estimates
|
|
Jul 30
|
Exploring US High Growth Tech Stocks For Potential Portfolio Expansion
|
|
Jul 30
|
High Growth Tech Stocks in the US Market July 2025
|
|
Jul 29
|
US High Growth Tech Stocks To Watch
|
|
Jul 29
|
US High Growth Tech Stocks To Watch In July 2025
|
|
Jul 23
|
Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025
|
|
Jul 18
|
Legend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains?
|
|
Jun 27
|
3 Promising Penny Stocks With Market Caps Under $400M
|
|
Jun 10
|
Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S
|
|
May 27
|
Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting
|
|
Apr 7
|
Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting
|
|
Apr 2
|
High Growth Tech Stocks In US With Promising Potential
|
|
Mar 31
|
Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia
|